By Reuters Staff
1 Min Read
PARIS, Jan 29 (Reuters) - If a vaccine demonstrates it is safe and efficient against the coronavirus, European Health authorities must at least review its possible use, Alain Fischer, the immunologist coordinating France’s vaccination strategy, said on Friday.
Fischer made the comments on BFM television after being asked about Hungary agreeing to buy doses of Chinese firm Sinopharm’s vaccine. (Reporting by Dominique Vidalon; Editing by Hugh Lawson)
A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.38% in a late-stage trial in Brazil, the company's local partners said on Tuesday, revealing a more modest figure after pressure for more transparency.